Unraveling the Impact of 177Lu-PSMA Radioligand Therapy on Renal Impairment: Distinguishing Causation from Correlation
- Author(s)
- Ravi Kumar, AS; Hofman, MS;
- Details
- Publication Year 2024-01-02,Volume 65,Issue #1,Page 85-86
- Journal Title
- Journal of Nuclear Medicine
- Publication Type
- Commentary
- Publisher
- Society of Nuclear Medicine and Molecular Imaging
- Keywords
- Humans; Male; *Dipeptides/adverse effects; Heterocyclic Compounds, 1-Ring; *Prostatic Neoplasms, Castration-Resistant; Prostate-Specific Antigen; Lutetium/therapeutic use
- Department(s)
- Cancer Imaging
- Publisher's Version
- https://doi.org/10.2967/jnumed.123.266638
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-02-20 07:04:48
Last Modified: 2024-02-20 07:05:27